Japanese Society of Neuroendovascular Therapy Data Base - Pipeline PREMIER

Japanese Society of Neuroendovascular Therapy Data Base - Pipeline PREMIER - JSNET-DB - Pipeline PREMIER

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041589

Enrollment

300

Registered

2020-09-01

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 patient who is scheduled or completed to endovascular treatment for intracranial aneurysm using Pipeline Flex to a. internal carotid artery: C2~C6 (AN diameter; 5mm to 10mm) b. internal carotid artery: C7 (AN diameter; over 5mm) c. vertebral artery: (AN diameter; over 5mm) 2 patient who has consent

Exclusion criteria

Exclusion criteria: No limitation

Design outcomes

Primary

Measure	Time frame
complete occlusion without re-treatment and severe stenosis of parent artery at 12 month after treatment	—

Secondary

Measure	Time frame
1 major stroke in the territory or neurological death at 12 month after treatment 2 occurrence rate of neurological death at 30days, 6mo, 12mo, 24mo and 36mo after treatment 3 occurrence rate of major stroke in the territory at 30days, 6mo, 12mo, 24mo and 36mo after treatment 4 occurrence rate of delayed intracranial hemorrhage 5 success rate of delivery device 6 relation of anti-platelet and event 7 adverse event and device failure within 3 years after treatment	—

Measure

Time frame

1 major stroke in the territory or neurological death at 12 month after treatment 2 occurrence rate of neurological death at 30days, 6mo, 12mo, 24mo and 36mo after treatment 3 occurrence rate of major stroke in the territory at 30days, 6mo, 12mo, 24mo and 36mo after treatment 4 occurrence rate of delayed intracranial hemorrhage 5 success rate of delivery device 6 relation of anti-platelet and event 7 adverse event and device failure within 3 years after treatment

—

Countries

Japan

Contacts

Public ContactChiaki Sakai

Kobe City Medical Center General Hospital Center for Clinical Research and Innovation

chiakmk@cronos.ocn.ne.jp078-302-4321

Outcome results